Automotive, Healthcare May 11, 2022 02:35 PM (GMT+8) · EqualOcean
GlaxoSmithKline (GSK) announced an innovative single-chip dual drug HIV treatment scheme. The expanded indications of dovidor (common name: Lamivudine dotilavir tablets) have been officially approved by the State Drug Administration of China. As a complete scheme, it is used to treat HIV-1 adults and adolescents over the age of 12 who have achieved virological inhibition. Previously, dovito was approved in March 2021 for the first treatment of HIV infected adults.